CCN2 and Blindness: Increasing levels of CTGF inactivate VEGF by reduction of production and complex formation, and when the equilibrium between these two factors shifts to a certain threshold ratio, the angio-fibrotic switch occurs and fibrosis driven by excess CTGF leads to scarring and blindness.